Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for reducing intraoperative bleeding in hip fracture fixation surgery
IRCT20191222045857N1Phase 3Completed
- Sponsor
- Aja University of Medical Sciences
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of dexmedetomidine in hip fracture (2 arms), sponsored by Aja University of Medical Sciences. Primary endpoints: bleeding volume, pulse rate and 1 more. Started Jun 2020; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
hip fracture
Beyond the preview
Go deeper on IRCT20191222045857N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191222045857N1.